Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
THRX: 53% | Theseus Pharmaceuticals Announces Process To Explore Strategic Alternatives
INVO: 51% | INVO BioScience GAAP EPS of -$0.70 beats by $0.17, revenue of $0.97M misses by $0.96M